OmniAb Business Combination Approved by APAC Shareholders

APAC Shareholder Approval Obtained, Closing Scheduled for November 1, 2022 Ligand “Regular Way” and “Ex-Distribution” and OmniAb “When-Issued” Set to Begin Trading on October 25, 2022 SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced the business combination (Business Combination) of Avista Public Acquisition Corp. II (APAC) (NASDAQ: AHPA) and OmniAb, Inc. (OmniAb), was approved … [Read more…]

Neuraptive Therapeutics Announces Key Organizational Updates to Support the Company’s Advancements in Nerve Repair

Evan Tzanis was appointed to the role of Chief Operating Officer Seth Schulman, M.D. joins as Chief Medical Officer Conversion of all previous notes into preferred shares PHILADELPHIA–(BUSINESS WIRE)–Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve … [Read more…]

HealthStream Announces Third Quarter 2022 Results

NASHVILLE, Tenn.–(BUSINESS WIRE)–HealthStream, Inc. (Nasdaq: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, announced today results for the third quarter ended September 30, 2022. Revenues of $67.3 million in the third quarter of 2022, up 5% from $64.1 million in the third quarter of 2021 Operating income of $2.4 million … [Read more…]

IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Credit Suisse Annual Healthcare Conference in Rancho Palos Verdes on Tuesday, November 8, 2022 at 12:10 p.m. ET (9:10 a.m. PT). A live audio webcast of the presentation will be … [Read more…]

Medpace Holdings, Inc. Reports Third Quarter 2022 Results

Revenue of $383.7 million in the third quarter of 2022 increased 29.8% from revenue of $295.6 million for the comparable prior-year period, representing a backlog conversion rate of 17.7%. Net new business awards were $470.9 million in the third quarter of 2022, representing an increase of 15.4% from net new business awards of $408.0 million … [Read more…]

Oragenics to Participate in the 2022 BioFlorida Annual Conference

TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conference, being held November 2-4 in Miami. Kim Murphy, President and CEO, will be participating on a panel titled “BioTrends: Learning from the Pandemic: The Fight … [Read more…]

Clemson University Team Wins Arrow Electronics “People’s Choice” Award and 2022 Collegiate Inventors Competition

CENTENNIAL, Colo.–(BUSINESS WIRE)–Student innovators from Clemson University swept to victory in the 2022 College Inventors Competition with a wireless device that protects patients from dangerous fluid pressure in the brain. The Clemson team won two prizes at the annual competition – the undergraduate top prize as well as the Arrow Electronics “People’s Choice” award. The … [Read more…]

WHOOP Announces Scientific Advisory Council to Advance Its Mission to Unlock Human Performance

The WHOOP Scientific Advisory Council will include medical and wellness experts such as Dr. Andrew Huberman, PhD, to enhance research and product innovation for improved holistic health outcomes BOSTON–(BUSINESS WIRE)–#huberman–WHOOP, the human performance company, today announced the launch of the WHOOP Scientific Advisory Council to enhance health research, influence product and feature innovations, and contribute … [Read more…]

United States Autism Treatment Centers Market Report 2022: A Fragmented $4 Billion Market – Growth of the Market from 2009 to 2019, 2020, 2021 Performance, 2022 and 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The U.S. Autism Treatment Centers Market” report from Marketdata LLC has been added to ResearchAndMarkets.com’s offering. This Marketdata study examines the fragmented $4+ billion U.S. growth market comprised of for-profit and non-profit providers that serve autistic patients via brick & mortar centers and in-home therapy provided by therapists. There are waiting lists, significant … [Read more…]

Naveris Collaborators Present Award-winning Abstract at ASTRO 2022 on Potential of NavDx to Inform Treatment Strategies in HPV-driven Cancers

NATICK, Mass.–(BUSINESS WIRE)–Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced that the company and the principle investigator at Mayo Clinic will present its award-winning abstract at the American Society for Radiation Oncology (ASTRO) Annual Meeting held October 23-26, 2022. This presentation describes significant new data supporting the clinical value of NavDx®, … [Read more…]